290 related articles for article (PubMed ID: 20563712)
21. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
22. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
[TBL] [Abstract][Full Text] [Related]
23. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7.
Kielsen K; Ryder LP; Lennox-Hvenekilde D; Gad M; Nielsen CH; Heilmann C; Ifversen M; Pedersen AE; Müller K
Immunobiology; 2018 Feb; 223(2):220-226. PubMed ID: 29033080
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
Niu YY; Ma LM; Zhou Y; Ren RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
27. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Brüggen MC; Klein I; Greinix H; Bauer W; Kuzmina Z; Rabitsch W; Kalhs P; Petzelbauer P; Knobler R; Stingl G; Stary G
Blood; 2014 Jan; 123(2):290-9. PubMed ID: 24255916
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
29. Donor-Derived Regulatory T Cells Attenuate the Severity of Acute Graft-Versus-Host Disease after Cord Blood Transplantation.
Zou X; Lin X; Luo W; Wei J
Tohoku J Exp Med; 2016 Jul; 239(3):193-202. PubMed ID: 27356468
[TBL] [Abstract][Full Text] [Related]
30. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
[TBL] [Abstract][Full Text] [Related]
31. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.
Jaskula E; Lange A; Dlubek D; Kyrcz-Krzemień S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Goździk J; Mizia S;
Tissue Antigens; 2013 Dec; 82(6):387-96. PubMed ID: 24498995
[TBL] [Abstract][Full Text] [Related]
32. Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.
Park MJ; Baek JA; Kim SY; Jung KA; Choi JW; Park SH; Kwok SK; Cho ML
J Transl Med; 2020 Dec; 18(1):483. PubMed ID: 33317573
[TBL] [Abstract][Full Text] [Related]
33. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
34. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
35. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
36. Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.
Chen X; Hill M; Vander Lugt M; Escolar M; Fang Z; Chen W; Szabolcs P
Cytotherapy; 2020 Mar; 22(3):149-157. PubMed ID: 32089448
[TBL] [Abstract][Full Text] [Related]
37. Correlation of Tc17 cells at early stages after allogeneic hematopoietic stem cell transplantation with acute graft-versus-host disease.
Wang L; Zhao P; Song L; Yan F; Shi C; Li Y; Han M; Lan K
Int Immunopharmacol; 2016 Dec; 41():122-126. PubMed ID: 27846420
[TBL] [Abstract][Full Text] [Related]
38. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
39. Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.
Malard F; Gaugler B; Lamarthee B; Mohty M
Mucosal Immunol; 2016 Mar; 9(2):299-308. PubMed ID: 26813345
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
